Abstract
The present disclosure provides a microbial consortium comprising two or more microorganisms, compositions and kits comprising the same and uses thereof for treating cancer.
Full Text
What is claimed is:
The present disclosure provides a microbial consortium comprising two or more microorganisms, compositions and kits comprising the same and uses thereof for treating cancer.
Timeline
Filed
04/21/2026Published
08/13/2026Granted
Not AvailableIPC Codes(4)
A61K 35/747:Lactobacilli, e.g. L. acidophilus or L. brevis
A61K 35/741:Probiotics (probiotic yeast, e.g. saccharomyces A61K 36/06)
A61K 35/742:Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes